Gina R Kruse1,2,3, Elyse R Park2,3,4, Yuchiao Chang1,3, Jessica E Haberer1,3,5, Lorien C Abroms6, Naysha N Shahid1, Sydney Howard1, Jennifer S Haas1,3, Nancy A Rigotti1,2,3. 1. Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston, MA. 2. Tobacco Research and Treatment Center, Department of Medicine, Massachusetts General Hospital, Boston, MA. 3. Department of Medicine, Harvard Medical School, Boston, MA. 4. Department of Psychiatry, Massachusetts General Hospital, Boston, MA. 5. Center for Global Health, Department of Medicine, Massachusetts General Hospital, Boston, MA. 6. Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University, Washington, DC.
Abstract
INTRODUCTION: Proactive, population health cessation programs can guide efforts to reach smokers outside of the clinic to encourage quit attempts and treatment use. AIMS AND METHODS: This study aimed to measure trial feasibility and preliminary effects of a proactive intervention offering text messages (TM) and/or mailed nicotine replacement therapy (NRT) to smokers in primary care clinics. From 2017 to 2019 we performed a pilot randomized trial comparing brief telephone advice (control: BA), TM, 2 weeks of mailed NRT, or both interventions (TM + NRT). Patients were identified using electronic health records and contacted proactively by telephone to assess interest in the study. We compared quit attempts, treatment use, and cessation in the intervention arms with BA. RESULTS: Of 986 patients contacted, 153 (16%) enrolled (mean age 53 years, 57% female, 76% white, 11% black, 8% Hispanic, 52% insured by Medicaid) and 144 (94%) completed the 12-week assessment. On average, patients in the TM arms received 159 messages (99.4% sent, 0.6% failed), sent 19 messages, and stayed in the program for 61 days. In all groups, a majority of patients reported quit attempts (BA 67% vs. TM 86% [p = .07], NRT 81% [p = .18], TM + NRT 79% [p = .21]) and NRT use (BA 51% vs. NRT 83% [p = .007], TM 65% [p = .25], TM + NRT 76% [p = .03]). Effect estimates for reported 7-day abstinence were BA 10% versus TM 26% (p = .09), NRT 28% (p = .06), and TM + NRT 23% (p = .14). CONCLUSIONS: Proactively offering TM or mailed nicotine medications was feasible among primary care smokers and a promising approach to promote quit attempts and short-term abstinence. IMPLICATIONS: Proactive intervention programs to promote quit attempts outside of office visits among smokers enrolled in primary care practices are needed. TM have potential to engage smokers not planning to quit or to support smokers to make a planned quit attempt. This pilot study demonstrates the feasibility of testing a proactive treatment model including TM and/or mailed NRT to promote quit attempts, treatment use, and cessation among nontreatment-seeking smokers in primary care. CLINICALTRIALS.GOV IDENTIFIER: NCT03174158.
RCT Entities:
INTRODUCTION: Proactive, population health cessation programs can guide efforts to reach smokers outside of the clinic to encourage quit attempts and treatment use. AIMS AND METHODS: This study aimed to measure trial feasibility and preliminary effects of a proactive intervention offering text messages (TM) and/or mailed nicotine replacement therapy (NRT) to smokers in primary care clinics. From 2017 to 2019 we performed a pilot randomized trial comparing brief telephone advice (control: BA), TM, 2 weeks of mailed NRT, or both interventions (TM + NRT). Patients were identified using electronic health records and contacted proactively by telephone to assess interest in the study. We compared quit attempts, treatment use, and cessation in the intervention arms with BA. RESULTS: Of 986 patients contacted, 153 (16%) enrolled (mean age 53 years, 57% female, 76% white, 11% black, 8% Hispanic, 52% insured by Medicaid) and 144 (94%) completed the 12-week assessment. On average, patients in the TM arms received 159 messages (99.4% sent, 0.6% failed), sent 19 messages, and stayed in the program for 61 days. In all groups, a majority of patients reported quit attempts (BA 67% vs. TM 86% [p = .07], NRT 81% [p = .18], TM + NRT 79% [p = .21]) and NRT use (BA 51% vs. NRT 83% [p = .007], TM 65% [p = .25], TM + NRT 76% [p = .03]). Effect estimates for reported 7-day abstinence were BA 10% versus TM 26% (p = .09), NRT 28% (p = .06), and TM + NRT 23% (p = .14). CONCLUSIONS: Proactively offering TM or mailed nicotine medications was feasible among primary care smokers and a promising approach to promote quit attempts and short-term abstinence. IMPLICATIONS: Proactive intervention programs to promote quit attempts outside of office visits among smokers enrolled in primary care practices are needed. TM have potential to engage smokers not planning to quit or to support smokers to make a planned quit attempt. This pilot study demonstrates the feasibility of testing a proactive treatment model including TM and/or mailed NRT to promote quit attempts, treatment use, and cessation among nontreatment-seeking smokers in primary care. CLINICALTRIALS.GOV IDENTIFIER: NCT03174158.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Rachael L Murray; Timothy Coleman; Marilyn Antoniak; Joanne Stocks; Alexia Fergus; John Britton; Sarah A Lewis Journal: Addiction Date: 2008-04-16 Impact factor: 6.526
Authors: Paul Krebs; Scott E Sherman; Hannah Wilson; Omar El-Shahawy; Lorien L Abroms; Xiaoquan Zhao; Shadi Nahvi; Donna Shelley Journal: Transl Behav Med Date: 2020-02-03 Impact factor: 3.046
Authors: Felix Naughton; Sue Cooper; Katharine Foster; Joanne Emery; Jo Leonardi-Bee; Stephen Sutton; Matthew Jones; Michael Ussher; Rachel Whitemore; Matthew Leighton; Alan Montgomery; Steve Parrott; Tim Coleman Journal: Addiction Date: 2017-05-02 Impact factor: 6.526
Authors: Lori A J Scott-Sheldon; Ryan Lantini; Ernestine G Jennings; Herpreet Thind; Rochelle K Rosen; Elena Salmoirago-Blotcher; Beth C Bock Journal: JMIR Mhealth Uhealth Date: 2016-05-20 Impact factor: 4.773
Authors: Patricia Chalela; Alfred L McAlister; Cliff Despres; Edgar Muñoz; Pramod Sukumaran; David Akopian; Sahak Kaghyan; Jesus Trujillo; Amelie G Ramirez Journal: JMIR Form Res Date: 2022-06-02
Authors: Chelsea M Cox; Jennifer C Westrick; Danielle E McCarthy; Matthew J Carpenter; Amanda R Mathew Journal: J Stud Alcohol Drugs Date: 2022-01 Impact factor: 2.582
Authors: E Melinda Mahabee-Gittens; Robert T Ammerman; Jane C Khoury; Meredith E Tabangin; Lili Ding; Ashley L Merianos; Lara Stone; Judith S Gordon Journal: Int J Environ Res Public Health Date: 2020-11-04 Impact factor: 3.390